Oxford Science Enterprises plc's Form 4/A amendment
AmendedBarinthus Biotherapeutics plc. (BRNS) · filed Sep 11, 2026
- Accession no.
- 0001856079-26-000002
- Filed
- Sep 11, 2026, 11:00 AM ET
- Trade date
- Sep 9, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
- Original filed
- May 6, 2021
This filing lists 1 non-derivative transaction and 0 derivative transactions. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Oxford Science Enterprises plcCIK 0001856079 | Other: former 10% owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 9, 2026 | Ordinary Shares | ULess common codeDisposed | −8,797,770 | $0.111 | −$976,552.47 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.